Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Siyu Liu


Research Assistant


α-thalassaemia is a haemoglobinopathy resulting from the impaired production of α-globin that occurs most frequently from deletions of the paralogous α-globin genes (HBA1 & HBA2). Homozygous deletion of these genes is termed α0-thalassaemia and causes lethal neonatal anaemia called Hb Barts’ Hydrops Fetalis Syndrome (BHFS).  The most common cause of α0-thalassaemia is a 20.5-kb deletion termed the South East Asian (SEA) deletion, which leaves the embryonically expressed ζ-globin gene (HBZ) intact and available for reactivation. Reactivating ζ-globin expression is, therefore, a potential therapeutic strategy to ameliorate the severe symptoms of α-thalassaemia. Separately, the silencing of the ζ-globin gene poses an important question in gene regulation as it lies immediately adjacent to the highly active α-globin enhancers and yet remains transcriptionally inactive in definitive erythroid cells. The silencing mechanism is poorly understood yet is of great interest and likely to be widely applicable. 

The core question I am addressing is determining the mechanism by which the embryonically expressed ζ-globin gene is silenced in adult erythroblasts and how it may be reactivated in patients with severe α-thalassaemia.